Movement Disorders

Filter Your Results




Investigational Tau Modifier Receives Orphan Drug Status for Progressive Supranuclear Palsy

Wednesday, July 18, 2018—The Food and Drug Administration (FDA) has granted an orphan drug designation to ASN120290 (Asceneuron SA, Lausanne, Switzerland) for the treatment of progressive supranuclear…

IncobotulinumtoxinA Approved for Treatment of Excessive Drooling

Friday, July 13, 2018—The Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for incobotulinumtoxin A (Xeomin; Merz, Raleigh, NC) for the treatmen…

New Dosing Formulation and Strength for Pimavanserin Approved

Friday, June 29, 2018—The Food and Drug Administration (FDA) has approved a new capsule dose formulation and a new tablet strength of pimavanserin (Nuplazid; Acadia Pharmaceuticals, San Diego, CA).…

New Monoclonal Antibodies Against Alpha-Synuclein Generated

Tuesday, June 26, 2018—ProMIS Neurosciences, Inc has announced that numerous antibodies against toxic oligomers of alpha-synuclein, implicated in Parkinson’s disease (PD) have begun the final …

Impulse Control Disorders More Common in People Who Take Dopamine Agonists

Wednesday, June 20, 2018—A French study which followed 411 people for an average of three years who had been diagnosed with Parkinson’s disease (PD) within 5 years, has reported an increase in i…

Medtronic Deep Brain Stimulation Clinician Programmer Receives FDA Approval

Wednesday, June 13, 2018—Medtronic announced that the Food and Drug Administration (FDA) had recently approved its Deep Brain Stimulation (DBS) Clinician Programmer and Activa Programming Application.…

Risk for Parkinson’s Disease May Be Linked to an Earlier Diagnosis of Diabetes

Wednesday, June 13, 2018—A study from England published online in Neurology on June 13 suggests that people with type 2 diabetes may have an increased risk of developing Parkinson&rsquo…

Medicare Benefit Coverage Available for MR-Guided Focused Ultrasound to Treat Essential Tremor

Monday, June 04, 2018—Magnetic resonance (MR)-guided focused ultrasound (MRgFUS) (INSIGHTEC, Miami, FL) for the treatment of essential tremor is now available as a medicare benefit in 10 states: Co…


Contact Info

For advertising rates and opportunities:
Wendy Terry

About Practical Neurology

Launched in 2002, Practical Neurology is a publication uniquely dedicated to presenting current approaches to patient management, synthesis of emerging research and data, and analysis of industry news with a goal to facilitate practical application and improved clinical practice for all neurologists. Our straightforward articles give neurologists tools they can immediately put into practice.